Therapeutic activity of Bacillus subtilis against some multidrug resistance bacterial pathogens isolated from burn infections

2022 ◽  
Author(s):  
Zahraa Hussein Ali ◽  
Nawfal Hussein Aldujaili
2019 ◽  
Vol 9 (02) ◽  
Author(s):  
Hussein A Kadhum ◽  
Thualfakar H Hasan2

The study involved the selection of two isolates from Bacillus subtilis to investigate their inhibitory activity against some bacterial pathogens. B sub-bacteria were found to have a broad spectrum against test bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa. They were about 23-30 mm and less against Klebsiella sp. The sensitivity of some antibodies was tested on the test samples. The results showed that the inhibitory ability of bacterial growth in the test samples using B. subtilis extract was more effective than the antibiotics used.


2020 ◽  
Vol 2 (1) ◽  
pp. 29

Based on the global environmental pollution problems, the main focus of every nano-research is to produce the nanomaterial in a green and eco-friendly way without any interference of chemical synthesis. By the way, the present study was intended to use an aqueous extract of the living fossil plant viz., Ginkgo biloba L., to synthesize the gold nanoparticles and evaluate their antibiotic activity against bacterial pathogens. The gold nanoparticles (AuNps) were successfully synthesized by mixing the Ginkgo biloba aqueous extract and the auric chloride solution for approximately 24 hours. The UV-Vis spectra of Gold nanoparticles (AuNps) showed the maximum absorption peak at 520nm. The SEM analysis also showed the gold nanoparticles synthesized from Ginkgo biloba were spherical with particle size ranging from 40 to 60nm. During our study, the gold nanoparticles exhibited significant antimicrobial activity against bacterial pathogens, i.e., E. coli and Bacillus subtilis. The later bacterium was found to be more susceptible to the nanoparticles as well as the extracts of G. biloba in comparison to the former bacterium.


Author(s):  
Sarim Ahmad ◽  
Shamim Ahmad ◽  
Faizan Abul Qais ◽  
Mohammad Shavez Khan ◽  
Iqbal Ahmad

2009 ◽  
Vol 191 (10) ◽  
pp. 3273-3281 ◽  
Author(s):  
Ji-Yun Kim ◽  
Takashi Inaoka ◽  
Kazutaka Hirooka ◽  
Hiroshi Matsuoka ◽  
Makiko Murata ◽  
...  

ABSTRACT Using comparative genome sequencing analysis, we identified a novel mutation in Bacillus subtilis that confers a low level of resistance to fusidic acid. This mutation was located in the mdtR (formerly yusO) gene, which encodes a MarR-type transcriptional regulator, and conferred a low level of resistance to several antibiotics, including novobiocin, streptomycin, and actinomycin D. Transformation experiments showed that this mdtR mutation was responsible for multidrug resistance. Northern blot analysis revealed that the downstream gene mdtP (formerly yusP), which encodes a multidrug efflux transporter, is cotranscribed with mdtR as an operon. Disruption of the mdtP gene completely abolished the multidrug resistance phenotype observed in the mdtR mutant. DNase I footprinting and primer extension analyses demonstrated that the MdtR protein binds directly to the mdtRP promoter, thus leading to repression of its transcription. Moreover, gel mobility shift analysis indicated that an Arg83 → Lys or Ala67 → Thr substitution in MdtR significantly reduces binding affinity to DNA, resulting in derepression of mdtRP transcription. Low concentrations of fusidic acid induced the expression of mdtP, although the level of mdtP expression was much lower than that in the mdtR disruptant. These findings indicate that the MdtR protein is a repressor of the mdtRP operon and that the MdtP protein functions as a multidrug efflux transporter in B. subtilis.


Sign in / Sign up

Export Citation Format

Share Document